The company is not worth any more than the offer.
The RAP board management have been given the message
The value for Pfizer is the Telehealth space, the distribution networks and the Pfizer planned apps to be used via smartphones
RAP’s is going know where without a massive injection of cash and RAP knows that institution support has had a guts full and retail support is of minimal value.
The RAP board has no alternative- the money/power has spoken
The Institution’s/Cash has spoken
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
